Challenge An oral solution used for radiological investigational purposes was facing a nation-wide shortage in the UK, due to issues with the Active Pharmaceutical Ingredient (API). Hospitals across the country needed this product urgently and [...]
Challenge A biopharma company developing a new drug for a rare form of cancer partnered with WEP Clinical to run an Expanded Access Program (EAP). Because the company’s drug is being developed to treat a [...]
Challenge A rare disease company developing a new drug for a lysosomal storage disorder partnered with WEP Clinical to run an Expanded Access Program (EAP). The drug was already being provided under various investigator-sponsored EAPs. [...]
Challenge An oncology product was in short supply all over Europe and hospitals in Spain were running out of stock. This was an important, first-line treatment, that was needed in large quantities for cancer patients. [...]
Challenge The Spain Country Manager asked for a new customer to be set up in our system the day before the Christmas holidays, so that an urgent shipment for a paediatric patient could be delivered [...]
Challenge WEP Clinical was in the sourcing phase for a particular specialty drug needed for a customer’s clinical trial. Due to the large quantity needed for the study, our authorized distributors could only agree to [...]